New hires and promotions in the med-tech industry, including: Geneoscopy, Nanalysis Scientific.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Amo, Asklepios, Biophytis, Glaukos, Orchard, PDS, Priothera, Replimune, Springworks.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Amarin, Catalyst, CSL, DMK, GC, Pfizer, Redhill, Sunshine, Tempus, Tevard, Theravance, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blueprint, Celldex, Chiesi, Clene, Elpiscience, Evelo, Hutchmed, Imunon, Levation, Maze, Mitsubishi Tanabe, Nexcella, Sanofi.

Biopharmas raising money in public or private financings, including: Apellis, Aprea, Contrafect, Oricell, Travere, Verismo.

New hires and promotions in the biopharma industry, including: Argenx, Enveric, Frontier Medicines, Korro, Longeveron, Sutro.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apyx Medical, Lucira Health, Milestone Scientific.

Med-tech firms raising money in public or private financings, including: Visionhealth.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: GE Healthcare, Iradimed, Macrogen, Monopar Therapeutics, Northstar Medical Radioisotopes, Orthoventions, Singleron, Sonde, Sonothera.